Jerry McLaughlin

Stories

First human trial of cellular rejuvenation therapy begins after two decades of research

As of May 2026: Leading company through its first clinical trial and $80M Series D raise

In 2006, Shinya Yamanaka showed that four genes could rewind an adult cell all the way back to an embryonic-like state. Twenty years later, a stripped-down version of that technique is being injected into human eyes for the first time.

Updated May 30